BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 17608956)

  • 1. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction.
    Nielsen M; Lund O
    BMC Bioinformatics; 2009 Sep; 10():296. PubMed ID: 19765293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
    Nielsen M; Lundegaard C; Blicher T; Peters B; Sette A; Justesen S; Buus S; Lund O
    PLoS Comput Biol; 2008 Jul; 4(7):e1000107. PubMed ID: 18604266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
    Jørgensen KW; Buus S; Nielsen M
    PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.
    Bordner AJ; Mittelmann HD
    BMC Bioinformatics; 2010 Sep; 11():482. PubMed ID: 20868497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules.
    Zhang L; Chen Y; Wong HS; Zhou S; Mamitsuka H; Zhu S
    PLoS One; 2012; 7(2):e30483. PubMed ID: 22383964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
    Salomon J; Flower DR
    BMC Bioinformatics; 2006 Nov; 7():501. PubMed ID: 17105666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms.
    Rajapakse M; Schmidt B; Feng L; Brusic V
    BMC Bioinformatics; 2007 Nov; 8():459. PubMed ID: 18031584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
    Xu Y; Luo C; Qian M; Huang X; Zhu S
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
    Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
    Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide binding predictions for HLA DR, DP and DQ molecules.
    Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
    BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.
    Andreatta M; Karosiene E; Rasmussen M; Stryhn A; Buus S; Nielsen M
    Immunogenetics; 2015 Nov; 67(11-12):641-50. PubMed ID: 26416257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative prediction of mouse class I MHC peptide binding affinity using support vector machine regression (SVR) models.
    Liu W; Meng X; Xu Q; Flower DR; Li T
    BMC Bioinformatics; 2006 Mar; 7():182. PubMed ID: 16579851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.